Acamprosate 333mg gastro-resistant tablets
BNF presentation 0410010A0AAAAAA within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0410010A0AAAAAA
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
38,533
NHS spend (£)
£554,003.77
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 5,058 |
| February 2025 | 44 |
| December 2024 | 1,695 |
| November 2024 | 5,637 |
| October 2024 | 5,838 |
| September 2024 | 36 |
| August 2024 | 482 |
| July 2024 | 5,748 |
| June 2024 | 4 |
| May 2024 | 1,576 |
| July 2021 | 2,029 |
| June 2021 | 1,480 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 187 | No data available |
| Unknown pharmacy | 166 | No data available |
| Unknown pharmacy | 116 | No data available |
|
Drighlington Medical Centre
ODS B86678
|
109 | 15F - WEST YORKSHIRE ICB |
| Unknown pharmacy | 102 | No data available |
| Unknown pharmacy | 98 | No data available |
| Unknown pharmacy | 90 | No data available |
| Unknown pharmacy | 85 | No data available |
| Unknown pharmacy | 82 | No data available |
| Unknown pharmacy | 82 | No data available |